Lindbrook Capital, LLC Corcept Therapeutics Inc Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Lindbrook Capital, LLC holds 196 shares of CORT stock, worth $9,794. This represents 0.0% of its overall portfolio holdings.

Number of Shares

196

Previous 196 -0.0%

Holding current value

$9,794

Previous $6,000 50.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$22.21 - $34.48 $1,776 - $2,758	80 Added 68.97%	196 $6,000
Q1 2024 Apr 25, 2024	BUY	$21.1 - $27.46 $42 - $54	2 Added 1.75%	116 $2,000
Q3 2023 Oct 25, 2023	BUY	$21.97 - $33.8 $395 - $608	18 Added 18.75%	114 $3,000
Q2 2023 Jul 28, 2023	SELL	$21.44 - $25.15 $1,800 - $2,112	-84 Reduced 46.67%	96 $2,000
Q1 2023 Apr 26, 2023	BUY	$19.2 - $24.47 $1,612 - $2,055	84 Added 87.5%	180 $3,000
Q4 2022 Jan 24, 2023	SELL	$19.95 - $29.96 $4,867 - $7,310	-244 Reduced 71.76%	96 $0
Q3 2022 Nov 10, 2022	BUY	$24.7 - $29.12 $6,026 - $7,105	244 Added 254.17%	340 $9,000
Q1 2022 Apr 21, 2022	SELL	$16.53 - $25.21 $1,619 - $2,470	-98 Reduced 50.52%	96 $2,000
Q4 2021 Jan 18, 2022	BUY	$17.1 - $23.34 $718 - $980	42 Added 27.63%	194 $4,000
Q3 2021 Nov 05, 2021	SELL	$19.68 - $22.53 $3,188 - $3,649	-162 Reduced 51.59%	152 $3,000
Q2 2021 Jul 27, 2021	BUY	$19.97 - $24.43 $1,557 - $1,905	78 Added 33.05%	314 $7,000
Q1 2021 Apr 28, 2021	BUY	$23.49 - $30.56 $1,385 - $1,803	59 Added 33.33%	236 $6,000
Q4 2020 Jan 27, 2021	BUY	$16.78 - $27.3 $1,359 - $2,211	81 Added 84.38%	177 $5,000
Q3 2020 Nov 03, 2020	BUY	$12.46 - $19.98 $573 - $919	46 Added 92.0%	96 $2,000
Q1 2020 Apr 22, 2020	BUY	$10.11 - $14.04 $505 - $702	50 New	50 $1,000

Others Institutions Holding CORT

# of Institutions

346

Shares Held

86.1M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.35B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Corcept Therapeutics Inc Transaction History